The study on World Pharmacogenomics — Future of Healthcare Industry 2009™ includes the identification of novel genomic targets for drug development, the clinical applications of genomics science, potential benefits of pharmacogenomics, effect of genetic variability on drug toxicity and efficacy.
Importantly, this market research report integrate new developments in genomics and proteomics to clinical medicine, pharmacology, and therapeutics and assess the trends, developments and challenges that the industry faces.
